Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life

P B Jeppesen, P Lund, I B Gottschalck, H B Nielsen, Jens Juul Holst, J Mortensen, S S Poulsen, Bjørn Quistorff, P B Mortensen

Fingeraftryk

Dyk ned i forskningsemnerne om 'Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab